Work

The effect of sex hormones on cognition and psychosis-like behaviour with relevance to schizophrenia

Year: 2017
Type: dissertation
Abstract: There is undeniable necessity for a novel pharmacological treatment for schizophrenia. Current treatment for the disorder, antipsychotics, are associated with several side effects and do not effectively treat the entire array of symptoms. The sex hormone, 17β-estradiol (17β), has demonstrated therapeutic effects in preclinical and clinical studies of schizophrenia. Unfortunately, long-term 17β treatment is associated with potential health risks and feminising side effects in men. The Selective Estrogen Receptor Modulator (SERM), raloxifene (RAL), is a feasible alternative to 17β, having demonstrated a beneficial effect in all schizophrenia symptom domains and in both sexes, albeit inconsistently between laboratory groups. Further, given their promising neuroprotective and cognitive-enhancing effects, the SERM, tamoxifen (TAM), and brain-synthesised estrogen, 17α-estradiol (17α), may also be feasible alternatives, however these compounds require validation in established animal models for psychosis. Thus, this thesis explored the effect of 17β, 17α, RAL, and TAM on schizophrenia-like behaviour in rats, using acute pharmacological models and the neurodevelopmental maternal immune activation (MIA) poly(I:C) model of schizophrenia. In the first experiment (Chapter 3), we assessed two psychosis-like behaviours, psychotomimetic drug-induced prepulse inhibition (PPI) deficits and locomotor hyperactivity, using the dopamine D1/D2 receptor agonist, apomorphine, the indirect dopamine releaser, methamphetamine, and the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801. Long Evans rats were ovariectomised to reduce endogenous hormones, which resulted in an impairment of baseline PPI, and all estrogenic compounds were able to successfully reverse this impairment. 17β treatment in OVX rats successfully attenuated dopaminergic drug-induced PPI disruption and locomotor hyperactivity, while RAL and TAM-treated OVX rats showed limited actions against psychosis-like behaviours, with TAM successfully attenuating both methamphetamine and apomorphine-induced disruption of PPI, and RAL only protecting against the latter. 17α, however, showed no protective effect in either assay. None of the estrogenic compounds significantly modulated NMDA receptor-mediated psychosis-like behaviour. These findings show that 17β, RAL, and TAM effectively modulate behavioural effects of dopaminergic stimulation, a key neurotransmitter system implicated in schizophrenia. To further explore these estrogenic compounds, we used the neurodevelopmental poly(I:C) model (Chapter 4). Pregnant dams were treated with saline or viral mimic, poly(I:C), at mid-late gestation, and adult offspring were tested in psychosis-like behaviours. Both male and female poly(I:C) offspring exhibited a baseline PPI deficit, and RAL and 17β treatment in intact female rats successfully reversed this deficit, however 17α had no significant effect. PPI in poly(I:C) offspring was significantly disrupted by apomorphine and MK-801 to a similar level of disruption as seen in the control offspring. Following methamphetamine, however, control offspring demonstrated an expected PPI impairment, while poly(I:C) offspring showed no disruption at all, suggesting an altered dopaminergic system. Male poly(I:C) offspring exhibited increased drug-induced locomotor hyperactivity (Chapter 5), however, female poly(I:C) offspring did not differ from control offspring. Regardless of condition, RAL and 17β treatment in intact female rats increased methamphetamine-induced hyperactivity, while 17α had no significant effect, and the effect of 17β in methamphetamine-induced hyperactivity was in contrast to its effect in OVX rats in Chapter 3, which we theorise is due to endogenous hormone profile. For the first time, the effect of OVX and estrous cycle was explored on performance in the rodent touchscreen apparatus. Using the Trial-Unique Nonmatching-to-Location (TUNL) task to test spatial working memory, results showed that OVX impaired (Chapter 6), and phase of estrous cycle altered performance (Chapter 7). Our findings highlight the importance of endogenous hormone profile for normal working memory performance. Further, using the touchscreen TUNL task, we found that male poly(I:C) offspring, but not female, exhibited a spatial working memory deficit. However, performance did not differ between conditions in pairwise discrimination and reversal learning, a task measuring cognitive flexibility. To summarise, this research found sex-specific alterations in psychosis-like behaviour and cognition in the poly(I:C) model of schizophrenia. Further, three estrogenic compounds, 17α, RAL, and TAM, had limited action on psychosis-like behaviour in both pharmacological and neurodevelopmental MIA models of schizophrenia. Ultimately, RAL exerted promising effects requiring exploration in future research, however, 17β exerted the most potent antipsychotic-like effect.
Author: Alyssa Sbisa
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2900142193
Cites: 483
Cited by: 1
Related to: 10